Loading clinical trials...

Association of TNFAIP3 With Immune-mediated TTP | Clinical Trials | Clareo Health

RECRUITINGNANCT06928233

Association of TNFAIP3 With Immune-mediated TTP

This study aims to investigate whether genetic variation in the TNFAIP3 locus is associated with immune-mediated thrombotic thrombocytopenic purpura (iTTP), and whether such association is mediated by...

Lead sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico•1 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Ilaria Mancini, PhD

CONTACT

+390255035414 ilaria.mancini@guest.unimi.it

Related studies

UNKNOWN

A Retrospective, Observational Study on the Response to Caplacizumab Treatment in aTTP Patients: the Italian Experience (ROSCAPLI)

NCT05262881 · Thrombotic Thrombocytopenic Purpura, Acquired

UNKNOWNPhase 4

Efficacy and Safety of Bortezomib as First-line Treatment of Acquired TTP

NCT05135442 · Thrombotic Thrombocytopenic Purpura, Acquired

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 27, 2026Terms

Trial snapshot

StatusRECRUITING

PhaseNA

Enrollment400

Start dateApr 2025

Last updatedMar 27, 2026

Condition

Thrombotic Thrombocytopenic Purpura, Acquired

Locations shown

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico

Milan

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 27, 2026Data synced to Clareo: April 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions